Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Resmed Inc
(NY:
RMD
)
227.50
+0.86 (+0.38%)
Streaming Delayed Price
Updated: 1:21 PM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Resmed Inc
< Previous
1
2
Next >
ResMed Expands its Board of Directors and Appoints Healthcare Executive and Seasoned Finance Leader Christopher DelOrefice to its Board
August 15, 2024
From
ResMed Inc.
Via
GlobeNewswire
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2024
August 01, 2024
From
ResMed Inc.
Via
GlobeNewswire
ResMed to Report Fourth Quarter Fiscal 2024 Earnings on August 1, 2024
July 03, 2024
From
ResMed Inc.
Via
GlobeNewswire
Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
July 01, 2024
Global pharmaceutical giant Eli Lilly & Co. (NYSE: LLY) has made headlines with its leading GLP-1 weight loss drugs, Mounjaro and Zepbound.
Via
MarketBeat
Exposures
Product Safety
PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia
June 10, 2024
ResMed studies presented at SLEEP 2024 also revealed a 17% prevalence of insomnia among adults in North America, Latin America, and the Caribbean, and a higher rate of depression in women with OSA
From
ResMed Inc.
Via
GlobeNewswire
Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy
May 23, 2024
From
ResMed Inc.
Via
GlobeNewswire
ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy
May 16, 2024
From
ResMed Inc.
Via
GlobeNewswire
MatrixCare Joins Health Gorilla’s Qualified Health Information Network (QHIN) to Enhance Patient Data Access
May 16, 2024
The alliance with Health Gorilla will provide MatrixCare customers with more than 220 million patient records to streamline workflows and improve patient outcomes.
From
MatrixCare
Via
GlobeNewswire
ResMed Announces Participation in the RBCCM Global Healthcare Conference
May 07, 2024
From
ResMed Inc.
Via
GlobeNewswire
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024
April 25, 2024
From
ResMed Inc.
Via
GlobeNewswire
ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024
April 04, 2024
From
ResMed Inc.
Via
GlobeNewswire
ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis
March 15, 2024
From
ResMed Inc.
Via
GlobeNewswire
Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed’s Smallest Full-Face CPAP Mask
March 06, 2024
From
ResMed Inc.
Via
GlobeNewswire
ResMed’s New AirCurve™ 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions about Care, Deliver Personalized Support, and Drive Positive Therapy Outcomes for Patients with Sleep Apnea
February 12, 2024
From
ResMed Inc.
Via
GlobeNewswire
MatrixCare Earns Three 2024 Best in KLAS Awards
February 07, 2024
MatrixCare has been named a market leader by KLAS Research for its Home Health EHR in three Categories: Home Health – Independent – Large, Home Health – Independent – Small, and Hospice – Independent
From
MatrixCare
Via
GlobeNewswire
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2024
January 24, 2024
From
ResMed Inc.
Via
GlobeNewswire
HCA Healthcare Rallies: Weight-loss drugs really a big threat?
January 08, 2024
HCA Healthcare rebounds amid concerns about weight-loss drugs' impact. The healthcare giant's revenue growth hints at resilience despite sector challenges.
Via
MarketBeat
Topics
ETFs
ResMed to Report Second Quarter Fiscal 2024 Earnings on January 24, 2024
January 03, 2024
From
ResMed Inc.
Via
GlobeNewswire
ResMed Announces Participation in the 42nd Annual J.P. Morgan Healthcare Conference
December 27, 2023
From
ResMed Inc.
Via
GlobeNewswire
ResMed Notifies Customers About Updated Instructions and Labeling for Masks with Magnets Due to Potential Interference with Certain Medical Devices
December 20, 2023
ResMed’s masks with magnets are safe when used in accordance with the updated Instructions for Use
From
ResMed Inc.
Via
GlobeNewswire
ResMed Secures Significant Victory in Patent Fight Against New York University
December 11, 2023
From
ResMed Inc.
Via
GlobeNewswire
Study Estimates a 23% Increase in COPD by 2050, Representing 600 Million Patients Globally
December 07, 2023
From
ResMed Inc.
Via
GlobeNewswire
ResMed Adopts New Operating Model to Accelerate Long-term Growth
November 09, 2023
From
ResMed Inc.
Via
GlobeNewswire
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2024
October 26, 2023
From
ResMed Inc.
Via
GlobeNewswire
ResMed to Report First Quarter Fiscal 2024 Earnings on October 26, 2023
October 05, 2023
From
ResMed Inc.
Via
GlobeNewswire
ResMed Announces Participation in Upcoming Conferences
September 05, 2023
From
ResMed Inc.
Via
GlobeNewswire
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2023
August 03, 2023
From
ResMed Inc.
Via
GlobeNewswire
ResMed to Report Fourth Quarter Fiscal 2023 Earnings on August 3, 2023
July 06, 2023
From
ResMed Inc.
Via
GlobeNewswire
ResMed Acquires Somnoware, a Leader in Digital Sleep and Respiratory Care Diagnostics Software
July 05, 2023
From
ResMed Inc.
Via
GlobeNewswire
PAP Adherence Lowers ER Visits 24-36% in 1 Year for People with Sleep Apnea and Heart Failure: ResMed Studies Presented at SLEEP
June 08, 2023
From
ResMed Inc.
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.